Monday, November 30, 2020

ALNY Alnylam Pharmaceuticals

 

ALNY has bounced of support at $120 4X, and is again showing bullish signs with the RSI crossing above 50. The stock has 10 analysts with a strong buy rating with price targets between $93-$225.

INO Inovio Pharma

 

INO twice found support at the $9 level, now starting to look bullish with moving averages turning up and RSI crossing above 50.